The strong results reflect disciplined operational execution across the group’s businesses and continued momentum in China.
Raffles Medical Group posted a 13.4% increase in its FY2025 ended December earnings to $70.6 million from $62.2 million a year ago.
The higher earnings were driven by improved performance from the Hospital Services and Insurance businesses, as well as fair value gains on investment properties. Revenue on the other hand saw a 1.8% y-o-y increase to $765.3 million, underpinned by higher patient volumes, improved average bill sizes and operational efficiencies.
